Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Contact Sensitization Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers

NCT01114841 is registered in ClinicalTrials.gov with Stiefel, a GSK Company as lead sponsor.

NCT NCT01114841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01114841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Evaluator-Blinded, Randomized, Vehicle Controlled, Study To Evaluate The Contact Sensitization Potential Of Topically Applied Tazarotene Foam In Healthy Volunteers
Lead sponsor
Stiefel, a GSK Company
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2010
Completion date
June 26, 2010
Enrollment
254 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris